Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$268.26 - $339.48 $15,290 - $19,350
-57 Reduced 4.25%
1,285 $350,000
Q1 2024

Apr 17, 2024

SELL
$304.11 - $351.99 $17,942 - $20,767
-59 Reduced 4.21%
1,342 $464,000
Q4 2023

Jan 23, 2024

SELL
$269.37 - $365.04 $8,619 - $11,681
-32 Reduced 2.23%
1,401 $452,000
Q3 2023

Oct 16, 2023

SELL
$350.25 - $422.63 $31,872 - $38,459
-91 Reduced 5.97%
1,433 $513,000
Q2 2023

Jul 19, 2023

SELL
$359.49 - $486.4 $109,644 - $148,352
-305 Reduced 16.68%
1,524 $577,000
Q1 2023

May 09, 2023

BUY
$418.69 - $503.0 $110,952 - $133,295
265 Added 16.94%
1,829 $876,000
Q4 2022

Jan 20, 2023

SELL
$351.71 - $456.01 $169,172 - $219,340
-481 Reduced 23.52%
1,564 $658,000
Q3 2022

Nov 02, 2022

SELL
$412.59 - $563.26 $3,713 - $5,069
-9 Reduced 0.44%
2,045 $853,000
Q2 2022

Jul 22, 2022

BUY
$463.67 - $597.16 $21,328 - $27,469
46 Added 2.29%
2,054 $1.02 Million
Q1 2022

Apr 20, 2022

SELL
$524.57 - $735.42 $96,520 - $135,317
-184 Reduced 8.39%
2,008 $1.13 Million
Q4 2021

Feb 02, 2022

BUY
$708.84 - $794.68 $126,173 - $141,453
178 Added 8.84%
2,192 $1.66 Million
Q3 2021

Nov 01, 2021

SELL
$657.71 - $825.77 $169,031 - $212,222
-257 Reduced 11.32%
2,014 $1.5 Million
Q2 2021

Jul 29, 2021

SELL
$576.64 - $649.04 $48,437 - $54,519
-84 Reduced 3.57%
2,271 $1.46 Million
Q1 2021

Apr 21, 2021

SELL
$547.01 - $662.35 $57,983 - $70,209
-106 Reduced 4.31%
2,355 $1.35 Million
Q4 2020

Feb 01, 2021

BUY
$510.68 - $643.45 $98,050 - $123,542
192 Added 8.46%
2,461 $1.44 Million
Q3 2020

Oct 29, 2020

SELL
$454.43 - $535.6 $33,627 - $39,634
-74 Reduced 3.16%
2,269 $1.17 Million
Q2 2020

Aug 04, 2020

BUY
$334.87 - $493.06 $784,600 - $1.16 Million
2,343 New
2,343 $1.06 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.